Source: International Congress 2018 – Clinical determinants and biomarkers of COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Majewski (Lodz, Poland), D. Tworek (Lodz, Poland), K. Szewczyk (Lodz, Poland), Z. Kurmanowska (Lodz, Poland), J. Kiszalkiewicz (Lodz, Poland), E. Brzezianska-Lasota (Lodz, Poland), H. Jerczynska (Lodz, Poland), A. Antczak (Lodz, Poland), W. Piotrowski (Lodz, Poland), P. Górski (Lodz, Poland). Overexpression of chitotriosidase and YKL-40 in serum and sputum in healthy smokers and patients with  chronic obstructive pulmonary disease. 2022

Member's Comments

No comment yet.

Related content which might interest you: Micro-RNA expression in induced sputum of smokers and patients with chronic obstructive pulmonary disease Source: Annual Congress 2010 - Genetics of obstruction Year: 2010 A study of the level of interleukin-32 in induced sputum and plasma of patients with chronic obstructive pulmonary disease and asthma Source: Annual Congress 2010 - Novel mechanisms in COPD Year: 2010 Serum leptin levels in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 259s Year: 2002 Comparison of serum osteopontin levels in patients with exacerbations and stable chronic obstructive pulmonary disease Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases Year: 2012 Roflumilast significantly decreased inflammatory biomarkers in induced sputum in current smokers patients with severe chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD treatment and varia Year: 2012 Association between serum YKL-40 and chronic obstructive pulmonary disease Source: International Congress 2017 – COPD biomarkers Year: 2017 C-reactive protein and serum amyloid A overexpression in lung tissues of chronic obstructive pulmonary disease patients Source: Annual Congress 2012 - Inflammatory mechanisms in COPD Year: 2012 The levels of serum malonyldialhyde and paraoxonase in chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: Suppl. 48, 305s Year: 2004 Serum magnesium levels of patients with chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: Suppl. 45, 107s Year: 2003 CC10 and TIMP1 levels in induced sputum of smokers who developed chronic airflow impairment Source: Annual Congress 2005 - Experimental approaches to the study of chronic cough and cigarette smoking Year: 2005 Elevated sputum BPIFB1 levels correlate with progression of chronic obstructive pulmonary disease Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015 Serum interferon-gamma levels in chronic obstructive pulmonary disease and asthma patients: correlation with respiratory parameters Source: Eur Respir J 2001; 18: Suppl. 33, 75s Year: 2001 Neutrophil elastase levels is higher in patients with lung cancer than chronic obstructive pulmonary disease Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer Year: 2011 Levels of CC-chemokines (MCP-1, MIP-1α, MIP-1β) in induced sputum of patients with chronic obstructive pulmonary disease and patients with chronic bronchitis Source: Eur Respir J 2001; 18: Suppl. 33, 194s Year: 2001 Serum angiopoietin-2 levels in stable and exacerbated chronic obstructive pulmonary disease Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema Year: 2015 Angiopoietins in sputum supernatant of patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring Year: 2010 Blood MCP-1 levels are increased in chronic obstructive pulmonary disease with prevalent emphysema Source: International Congress 2018 – Biomarkers of COPD Year: 2018 Proteomic analysis of plasma from COPD patients and smoking control subjects Source: Annual Congress 2007 - Novel therapeutic targets and disease markers in pulmonary pathology Year: 2007 Late Breaking Abstract - Increased serum levels of YKL-40 in male smoking chronic obstructive pulmonary disease patients associated with altered miRNA levels in alveolar macrophages Source: Virtual Congress 2020 – New biomarkers for management of obstructive diseases Year: 2020 Serum amyloid A in patients with stable chronic obstructive pulmonary disease Source: International Congress 2018 – Clinical determinants and biomarkers of COPD Year: 2018